ZIO-201

DRUG2 trials

Sponsors

Alaunos Therapeutics

Conditions

Advanced CancerAdvanced Sarcoma

Phase 1

A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard (IPM) in Patients With Advanced Cancer

CompletedNCT00421135

Alaunos TherapeuticsAdvanced Cancer

Start: 2006-02-28End: 2007-10-31Target: 30Updated: 2009-09-17

Study of ZIO-201 in Advanced Sarcoma

CompletedNCT00439686

Alaunos TherapeuticsAdvanced Sarcoma

Start: 2006-02-28End: 2013-12-31Updated: 2014-01-31